animalPublished 2015
Oral Sidr Dose-Response in Ethanol Gastric Challenge (Animal Model)
Effectiveness of Sidr honey on the prevention of ethanol-induced gastroulcerogenesis: role of antioxidant and antiapoptotic mechanism
Taha MME, Abdelwahab SI, Elsanousi R, et al. — Pharmacognosy Journal 7(3), 157–163 (2015)
Key Metric
100–500
mg/kg oral dose range in rats
Sample & Study Design
Preclinical rat model comparing three oral Sidr doses (100, 250, 500 mg/kg) against omeprazole prior to acute ethanol challenge.
Sample tested: Sidr honey tested at Jazan University
Measured Observation
Researchers observed dose-dependent protection of mucosal tissue and reduced oxidative stress markers across all three oral dose tiers.
Methodology Notes
- Demonstrated a measurable dose-response gradient rather than a flat binary threshold.
- Measured oxidative tissue markers alongside histology.
Methodological Limitations & Caveats
- Preclinical rodent study; does not translate directly to human dietary dosing or clinical treatment.
- Acute concentrated ethanol injury is a laboratory stress model, not typical human physiology.
- No follow-up human randomized clinical trial has confirmed these findings.
View Original Paper / CitationSummary for educational reference only; not medical advice.